Hospital-Acquired Hyperkalemia Events in Older Patients Are Mostly Due to Avoidable, Multifactorial, Adverse Drug Reactions.


Journal

Clinical pharmacology and therapeutics
ISSN: 1532-6535
Titre abrégé: Clin Pharmacol Ther
Pays: United States
ID NLM: 0372741

Informations de publication

Date de publication:
03 2019
Historique:
received: 12 07 2018
accepted: 10 09 2018
pubmed: 23 9 2018
medline: 20 12 2019
entrez: 23 9 2018
Statut: ppublish

Résumé

Drug-induced hyperkalemia is a frequent and severe complication in the hospital setting. Other risk factors may also induce hyperkalemia but the combination of drugs and precipitating factors has not been extensively studied. The aim was to identify drug-induced hyperkalemia events in hospitalized older patients and to describe their combinations with precipitating factors. Two experts independently analyzed retrospective data of patients aged 75 years or more. Experts identified 471 hyperkalemia events and concluded that 379 (80.5%) were induced by drugs. The cause was multifactorial (i.e., at least one drug with a precipitating factor) in 300 (79.2%) of the 379 drug-induced hyperkalemia. Most of the drug-induced hyperkalemia events were avoidable (79.9%)-mainly because of the multifactorial cause (e.g., dosage adaptation during acute kidney injury). Drug-induced hyperkalemia events are frequently combined with precipitating factors in hospitalized older patients and their prevention should focus on these combinations.

Identifiants

pubmed: 30242829
doi: 10.1002/cpt.1239
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

754-760

Informations de copyright

© 2018 American Society for Clinical Pharmacology and Therapeutics.

Auteurs

Laurine Robert (L)

Univ. Lille, EA 2694 - Santé publique: épidémiologie et qualité des soins, F-59000, Lille, France.

Grégoire Ficheur (G)

Univ. Lille, EA 2694 - Santé publique: épidémiologie et qualité des soins, F-59000, Lille, France.
Department of Public health, CHU Lille, F-59000, Lille, France.

Bertrand Décaudin (B)

Univ. Lille, EA 7365 - GRITA - Groupe de Recherche sur les Injectables et les Technologies Associées, F-59000, Lille, France.
Department of Pharmacy, CHU Lille, F-59000, Lille, France.

Juliette Gellens (J)

Univ. Lille, EA 2694 - Santé publique: épidémiologie et qualité des soins, F-59000, Lille, France.

Michel Luyckx (M)

Univ. Lille, EA 7365 - GRITA - Groupe de Recherche sur les Injectables et les Technologies Associées, F-59000, Lille, France.
Department of Pharmacy, CH Denain, F-59220, Denain, France.

Renaud Perichon (R)

Univ. Lille, EA 2694 - Santé publique: épidémiologie et qualité des soins, F-59000, Lille, France.

Sophie Gautier (S)

Department of Pharmacology, CHU Lille, F-59000, Lille, France.

François Puisieux (F)

Univ. Lille, EA 2694 - Santé publique: épidémiologie et qualité des soins, F-59000, Lille, France.
Department of Geriatrics, CHU Lille, F-59000, Lille, France.

Emmanuel Chazard (E)

Univ. Lille, EA 2694 - Santé publique: épidémiologie et qualité des soins, F-59000, Lille, France.
Department of Public health, CHU Lille, F-59000, Lille, France.

Jean-Baptiste Beuscart (JB)

Univ. Lille, EA 2694 - Santé publique: épidémiologie et qualité des soins, F-59000, Lille, France.
Department of Geriatrics, CHU Lille, F-59000, Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH